Compugen (CGEN) Director Perry Eran Receives Awards

What Happened

• Perry Eran, a director of Compugen Ltd. (CGEN), received two equity awards on 2026-07-29: 7,500 restricted stock units (RSUs) and a 10,000‑share option (reported as a derivative). Both were granted at $0.00 per share (no cash paid by the insider at grant).

Key Details

• Transaction date: 2026-07-29; filing date: 2026-07-30 (filed promptly the next day).
• Reported price: $0.00 for both awards; total cash paid = $0.
• Vesting: RSUs (F1) vest 25% on Oct 1, 2027, then the remainder vests in 12 equal quarterly installments thereafter, subject to continued service. The option (F2) follows the same vesting schedule.
• Shares owned after the transaction: not specified in the provided filing.
• Transaction code: A = Award/Grant. This was a grant (not an exercise or sale); no immediate sale or cashless exercise was reported.

Context

• These awards are typical compensation/retention grants that only convert to owned shares over time as they vest. The option grant is a derivative award and has not been exercised; it simply gives the holder the right to acquire shares in the future (subject to vesting and any exercise terms).